PRN: Fibromyalgia Drugs Price Analysis and Strategies 2016-2021: Price Data for Market Sizing, Drug Sales Forecast, Budgeting, Competitive Intelligence, HEOR, and Reimbursement - Research and Markets

23/feb/2017 22:00:22 PR Newswire Turismo Contatta l'autore

Questo comunicato è stato pubblicato più di 1 anno fa. Le informazioni su questa pagina potrebbero non essere attendibili.

Fibromyalgia Drugs Price Analysis and Strategies 2016-2021: Price Data for Market Sizing, Drug Sales Forecast, Budgeting, Competitive Intelligence, HEOR, and Reimbursement - Research and Markets

 
[23-February-2017]
 

DUBLIN, Feb. 23, 2017 /PRNewswire/ --

Research and Markets has announced the addition of the "Fibromyalgia Drugs Price Analysis and Strategies - 2016" report to their offering.

The latest research Fibromyalgia Drugs Price Analysis and Strategies - 2016, provides drug pricing data and benchmarks in the global Fibromyalgia market.

The research answers the following questions:

  • What are the key drugs marketed for Fibromyalgia and their clinical attributes? How are they positioned in the Global Fibromyalgia market?
  • What are the unit prices and annual treatment cost for Fibromyalgia therapies in different countries? What are the drug pricing trends and how are they expected to change in the future? How are the drug pricing and reimbursement landscape different by countries?
  • What are the unmet needs in the global Fibromyalgia drugs market? What would be the ideal pricing strategy for a new pipeline therapy for Fibromyalgia?

Research Scope:

  • Fibromyalgia Treatment Options - Identify key drugs marketed and prescribed for Fibromyalgia in the US, Germany, France, Italy, Spain, UK, Japan including trade name, molecule name, and company
  • Fibromyalgia Drugs Attributes - Find out the safety, efficacy, and risk benefit for key drugs marketed for Fibromyalgia
  • Market Positioning - Identify how drugs are clinically and commercially positioned in the global Fibromyalgia market
  • Fibromyalgia Drugs Price Analysis - Find out the annual therapy cost and unit price for key drugs marketed for Fibromyalgia in the US, Germany, France, Italy, Spain, UK, Japan. Find out how the price advanced from 2012 and forecast to 2021
  • Pricing & Reimbursement Landscape - Find out the pricing and reimbursement landscape in the US, Germany, France, Italy, Spain, UK, Japan
  • Fibromyalgia New Drug Pricing - Identify the effective pricing strategy for a new drug launch in the US, Germany, France, Italy, Spain, UK, Japan

This research will help executives

  • Identify clinical attributes of your competitor drugs
  • Find out how the marketed products for Fibromyalgia are clinically and commercially positioned
  • Understand the price of your competitor drugs by countries
  • Use Fibromyalgia drugs price data for market sizing, drug sales forecast, budgeting, competitive intelligence, HEOR, and reimbursement
  • Find out the pricing and reimbursement landscape by countries
  • Identify the unmet need in global Fibromyalgia market
  • Identify the effective pricing for a new drug

For more information about this report visit http://www.researchandmarkets.com/research/lpw5tz/fibromyalgia

Media Contact:

Laura Wood, Senior Manager
press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

 

blog comments powered by Disqus
Comunicati.net è un servizio offerto da Factotum Srl